SBC Medical Group Holdings Incorporated (SBCWW) Financial Ratios
4 years of historical data (2022–2025) · Industrials · Consulting Services
EV/EBITDA
↓
-1.32
—
5yr avg: N/A
P/FCF
↑
0.53
+3% vs avg
5yr avg: 0.51
30Y Low0.4·High0.6
P/B Ratio
↓
0.07
↓-27% vs avg
5yr avg: 0.10
30Y Low0.1·High0.1
ROE
↑
22.2%
↓+2% vs avg
5yr avg: 21.7%
30Y Low6%·High31%
Debt/EBITDA
↑
0.74
↑+64% vs avg
5yr avg: 0.45
30Y Low0.2·High0.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SBCWW Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
SBC Medical Group Holdings Incorporated trades at 0.4x earnings, 18% below its 5-year average of 0.5x, sitting at the 0th percentile of its historical range. Compared to the Industrials sector median P/E of 25.6x, the stock trades at a discount of 99%. On a free-cash-flow basis, the stock trades at 0.5x P/FCF, roughly in line with the 5-year average of 0.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $19M | $21M | $23M | — | — |
| Enterprise Value | $-92897476 | $-90961282 | $-89645653 | — | — |
| P/E Ratio → | 0.37 | 0.41 | 0.50 | — | — |
| P/S Ratio | 0.11 | 0.12 | 0.11 | — | — |
| P/B Ratio | 0.07 | 0.08 | 0.12 | — | — |
| P/FCF | 0.53 | 0.58 | 0.45 | — | — |
| P/OCF | 0.49 | 0.54 | 0.42 | — | — |
P/E links to full P/E history page with 30-year chart
SBCWW EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | -0.52 | -0.44 | — | — |
| EV / EBITDA | -1.32 | -1.30 | -1.21 | — | — |
| EV / EBIT | -1.38 | -1.11 | -1.22 | — | — |
| EV / FCF | — | -2.49 | -1.73 | — | — |
SBCWW Profitability
Margins and return-on-capital ratios measuring operating efficiency
SBC Medical Group Holdings Incorporated earns an operating margin of 38.9%, significantly above the Industrials sector average of 4.3%. Operating margins have expanded from 36.5% to 38.9% over the past 3 years, signaling improving operational efficiency. ROE of 22.2% indicates solid capital efficiency, compared to the sector median of 8.2%. ROIC of 43.4% represents excellent returns on invested capital versus a sector median of 6.1%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.3% | 76.0% | 70.9% | 65.9% |
| Operating Margin | 38.9% | 38.9% | 34.2% | 36.5% | 11.6% |
| Net Profit Margin | 29.4% | 29.4% | 22.7% | 20.3% | 3.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 22.2% | 22.2% | 27.5% | 31.3% | 5.9% |
| ROA | 15.8% | 15.8% | 17.8% | 16.3% | 2.8% |
| ROIC | 43.4% | 43.4% | 72.3% | 78.0% | 20.9% |
| ROCE | 25.7% | 25.7% | 37.9% | 48.6% | 16.2% |
SBCWW Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
SBC Medical Group Holdings Incorporated carries a Debt/EBITDA ratio of 0.7x, which is very conservative (77% below the sector average of 3.2x). The company holds a net cash position — cash of $164M exceeds total debt of $52M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 512.0x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.20 | 0.06 | 0.16 | 0.15 |
| Debt / EBITDA | 0.74 | 0.74 | 0.16 | 0.28 | 0.62 |
| Net Debt / Equity | — | -0.43 | -0.58 | -0.56 | -0.33 |
| Net Debt / EBITDA | -1.60 | -1.60 | -1.52 | -0.97 | -1.37 |
| Debt / FCF | — | -3.07 | -2.17 | -2.03 | — |
| Interest Coverage | 512.05 | 512.05 | 2596.61 | 1625.56 | 754.05 |
Net cash position: cash ($164M) exceeds total debt ($52M)
SBCWW Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
SBC Medical Group Holdings Incorporated's current ratio of 3.78x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.79x to 3.78x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 3.78 | 3.78 | 3.01 | 1.79 | 1.12 |
| Quick Ratio | 3.74 | 3.74 | 2.99 | 1.76 | 1.10 |
| Cash Ratio | 2.68 | 2.68 | 2.04 | 1.11 | 0.53 |
| Asset Turnover | — | 0.46 | 0.77 | 0.75 | 0.77 |
| Inventory Turnover | 16.59 | 16.59 | 33.02 | 18.19 | 43.94 |
| Days Sales Outstanding | — | 110.62 | 85.63 | 100.20 | 91.47 |
SBCWW Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
SBC Medical Group Holdings Incorporated returns 26.0% to shareholders annually primarily through share buybacks. The earnings yield of 100.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 100.0% | 243.2% | 199.9% | — | — |
| FCF Yield | 100.0% | 172.6% | 224.0% | — | — |
| Buyback Yield | 26.0% | 23.6% | 0.0% | — | — |
| Total Shareholder Yield | 26.0% | 23.6% | 0.0% | — | — |
| Shares Outstanding | — | $103M | $97M | $94M | $15M |
Peer Comparison
Compare SBCWW with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SBCWWYou | $19M | 0.4 | -1.3 | 0.5 | 73.3% | 38.9% | 22.2% | 43.4% | 0.7 |
 SKIN | $86M | -4.1 | 51.0 | 2.3 | 65.3% | -6.9% | -16.9% | -6.8% | 83.3 |
 DERM | $171M | -13.2 | — | — | 59.3% | -13.2% | -44.0% | -36.8% | — |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 SSKN | $806683 | -0.1 | — | — | 58.3% | -19.0% | -158.9% | -34.4% | — |
 ESTA | $2B | -49.3 | — | — | 69.3% | -18.5% | -133.3% | -14.6% | — |
 INMD | $849M | 9.4 | 6.5 | 10.1 | 78.5% | 23.0% | 13.5% | 13.5% | 0.2 |
 EW | $50B | 47.7 | 26.8 | 37.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 ISRG | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
| Industrials Median | — | 25.6 | 13.9 | 20.0 | 32.0% | 4.3% | 8.2% | 6.1% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
SBCWW — Frequently Asked Questions
Quick answers to the most common questions about buying SBCWW stock.
What is SBC Medical Group Holdings Incorporated's P/E ratio?
SBC Medical Group Holdings Incorporated's current P/E ratio is 0.4x. The historical average is 0.5x.
What is SBC Medical Group Holdings Incorporated's EV/EBITDA?
SBC Medical Group Holdings Incorporated's current EV/EBITDA is -1.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
What is SBC Medical Group Holdings Incorporated's ROE?
SBC Medical Group Holdings Incorporated's return on equity (ROE) is 22.2%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 21.7%.
Is SBCWW stock overvalued?
Based on historical data, SBC Medical Group Holdings Incorporated is trading at a P/E of 0.4x. Compare with industry peers and growth rates for a complete picture.
What are SBC Medical Group Holdings Incorporated's profit margins?
SBC Medical Group Holdings Incorporated has 73.3% gross margin and 38.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does SBC Medical Group Holdings Incorporated have?
SBC Medical Group Holdings Incorporated's Debt/EBITDA ratio is 0.7x, indicating low leverage. A ratio below 2x is generally considered financially healthy.